Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maze Therapeutics (MAZE) Prepaid Assets (2024 - 2026)

Maze Therapeutics' Prepaid Assets history spans 3 years, with the latest figure at $7.4 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 38.7% to $7.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.4 million, a 38.7% increase, with the full-year FY2025 number at $7.8 million, up 60.53% from a year prior.
  • Prepaid Assets hit $7.4 million in Q1 2026 for Maze Therapeutics, down from $7.8 million in the prior quarter.
  • Over the last five years, Prepaid Assets for MAZE hit a ceiling of $7.8 million in Q4 2025 and a floor of $4.9 million in Q4 2024.
  • Historically, Prepaid Assets has averaged $6.6 million across 3 years, with a median of $7.0 million in 2025.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 60.53% in 2025 and later skyrocketed 38.7% in 2026.
  • Tracing MAZE's Prepaid Assets over 3 years: stood at $4.9 million in 2024, then surged by 60.53% to $7.8 million in 2025, then decreased by 5.17% to $7.4 million in 2026.
  • Business Quant data shows Prepaid Assets for MAZE at $7.4 million in Q1 2026, $7.8 million in Q4 2025, and $7.4 million in Q3 2025.